Tony Chen Email

President and CEO . PrimeVax Immuno-Oncology

San Francisco, CA

Location

Current Roles

Employees:
7
Revenue:
$1.1M
About
PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
PrimeVax Immuno-Oncology Address
400 Cypress Ave
San Francisco, CA
United States
PrimeVax Immuno-Oncology Email